The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

The University of Kansas Cancer Center
R

Prevention and Treatment of Disease Relapse After Allogeneic HCT

By The University of Kansas Cancer Center FEATURING Robert Soiffer
By The University of Kansas Cancer Center FEATURING Robert Soiffer
1 view
June 2, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
40:05
The University of Kansas Cancer Center

Mitigating Toxicities Associated With CAR T-Cell Therapies

Feat. S. Kenderian
30:52
The University of Kansas Cancer Center

Treatment of Aggressive B-Cell Lymphoma: SCT vs. CAR-T

Feat. M. Hamadani
30:18
The University of Kansas Cancer Center

Survivorship and Late Effects After Stem Cell Transplantation and CA…

Feat. N. Ahmed
41:31
The University of Kansas Cancer Center

HaploSCT: Choosing an Optimal Donor and Novel Strategies to Mitigate…

Feat. J. McGuirk
43:41
The University of Kansas Cancer Center

Prevention and Treatment of Disease Relapse After Allogeneic HCT

Feat. R. Soiffer
30:51
The University of Kansas Cancer Center

Preventing Post-Transplant Relapse With Targeted Therapies

Feat. M. Levis